Abstract
Increasing evidences show that immune response affects the reparative mechanisms in injured brain. Recently, we have demonstrated that CD4 +T cells serve as negative modulators in neurogenesis after stroke, but the mechanistic detail remains unclear. Glucocorticoid-induced tumor necrosis factor (TNF) receptor (GITR), a multifaceted regulator of immunity belonging to the TNF receptor superfamily, is expressed on activated CD4 +T cells. Herein, we show, by using a murine model of cortical infarction, that GITR triggering on CD4 +T cells increases poststroke inflammation and decreases the number of neural stem/progenitor cells induced by ischemia (iNSPCs). CD4 +GITR +T cells were preferentially accumulated at the postischemic cortex, and mice treated with GITR-stimulating antibody augmented poststroke inflammatory responses with enhanced apoptosis of iNSPCs. In contrast, blocking the GITR-GITR ligand (GITRL) interaction by GITR-Fc fusion protein abrogated inflammation and suppressed apoptosis of iNSPCs. Moreover, GITR-stimulated T cells caused apoptosis of the iNSPCs, and administration of GITR-stimulated T cells to poststroke severe combined immunodeficient mice significantly reduced iNSPC number compared with that of non-stimulated T cells. These observations indicate that among the CD4 +T cells, GITR +CD4 +T cells are major deteriorating modulators of poststroke neurogenesis. This suggests that blockade of the GITR-GITRL interaction may be a novel immune-based therapy in stroke. © 2012 Macmillan Publishers Limited. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Takata, M., Nakagomi, T., Kashiwamura, S., Nakano-Doi, A., Saino, O., Nakagomi, N., … Matsuyama, T. (2012). Glucocorticoid-induced TNF receptor-triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke. Cell Death and Differentiation, 19(5), 756–767. https://doi.org/10.1038/cdd.2011.145
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.